The Latin America, Middle East and Africa Veterinary oncology Market would witness market growth of 14.2% CAGR during the forecast period (2020-2026).
Veterinary radiation oncology continues to advance with the introduction of emerging technology, procedures, and guidelines while growing patient outcome knowledge. They do face gaps in expertise and require randomized clinical trials to evaluate true results for clinicians, prognostic factors, dose tolerances, and toxicity.
In animals, lymphoma (lymphosarcoma) is a type of cancer characterized by the proliferation of malignant lymphocytes in solid organs such as the lymph nodes, bone marrow, liver, and spleen. The disorder can also occur in the gastrointestinal tract of the body, skin, and. Close supervision of dogs receiving chemotherapy is necessary because of the high risk of recurrence and resulting problems. The same refers to dogs who have reached remission and have ceased treatment. Disease and remission/recurrence control is normally done by peripheral lymph node palpation. This detects significant changes in peripheral lymph nodes. Some of the blood testing used to detect lymphoma often provide more objectivity and provide an early warning of an animal coming out of remission.
Wide resection is a type of curative-intent surgery: the aim is to resect the tumor burdens macroscopic (the primary tumor) and microscopic (satellite cells), including biopsy tracks. This surgical dosage is recommended for treating and handling solid tumors over intralesional and partial resections. Radical resection involves the replacement of a whole compartment of the tissue. Examples include removing a whole organ for the diagnosis of appendicular osteosarcomas, such as splenectomy to remove a splenic hemangiosarcoma or amputation of legs. Radical resection is sometimes required to completely remove the primary tumor and its accompanying pseudocapsule and satellite tumor cells, based on tumor location, type, and size.
Based on Animal Type, the market is segmented into Canine and Feline. Based on Therapy, the market is segmented into Chemotherapy, Radiology, Surgery, Immunotherapy and Others. Based on Cancer Type, the market is segmented into Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Karyopharm Therapeutics, Inc., Regeneus Ltd., Elanco Animal Health, Inc., Zoetis, Inc., Varian Medical Systems, Inc., PetCure Oncology, LLC (Accelitech, LLC), AB Science SA, Rhizen Pharmaceuticals S.A., and Nippon Zenyaku Kogyo Co., Ltd.
Scope of the Study
By Animal Type
• Canine and
• Immunotherapy and
By Cancer Type
• Mast Cell Cancer
• Mammary & Squamous Cell Cancer and
• Saudi Arabia
• South Africa
• Rest of LAMEA
• Boehringer Ingelheim International GmbH
• Karyopharm Therapeutics, Inc.
• Regeneus Ltd.
• Elanco Animal Health, Inc.
• Zoetis, Inc.
• Varian Medical Systems, Inc.
• PetCure Oncology, LLC (Accelitech, LLC)
• AB Science SA
• Rhizen Pharmaceuticals S.A.
• Nippon Zenyaku Kogyo Co., Ltd.
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
U.S. Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Surgery, Radiology, Chemotherapy, Immunotherapy), By Animal Type (Canine, Feline), And Segment Forecasts, 2021 - 2028 U.S. Veterinary Oncology Market Growth & Trends The U.S. veterinary oncology market size is expected...
The Middle East and Africa multiple sclerosis therapeutics market is expected to reach US$ 2,027.86 million by 2027 from US$ 1,319.08 million in 2019; it is estimated to grow at a CAGR of 5.7% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as increasing awareness about multiple sclerosis amongst...
Left Ventricular Dysfunction (Cardiovascular) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Drugs in Development, 2021, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left...
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....
The Veterinary Pain management market was valued at USD 1,197 million in 2020, and it is expected to reach USD 1,910 million in 2026, registering a CAGR of nearly 6.30% during the forecast period. The global outbreak of COVID-19 has impacted all industries including veterinary pain medicine. Pet parents are advised to keep a safe distance...
The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing...
The Latin America, Middle East and Africa Digital Therapeutics Market would witness market growth of 22.8% CAGR during the forecast period (2021-2027). There is an increasing demand for digital therapeutics across the globe, due to the rising adoption of smartphones & tablets along with healthcare apps, increasing cases of chronic diseases,...
The peptide therapeutics market was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.2% during 2020–2027. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic...
“CAR T-Cell Therapy for Non-Hodgkin’s lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Non-Hodgkin’s lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics...
‘Von Willebrand disease – Market Insights, Epidemiology, and Market Forecast-2030’ report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of Von Willebrand disease in Algeria, Egypt, Saudi Arabia, South Africa and the United Arab Emirates.
The Von Willebrand disease...
United Arab Emirates
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.